• Nenhum resultado encontrado

Hepatitis C (HCV)

NEW THERAPIES FOR HEPATITIS C

NEW THERAPIES FOR HEPATITIS C

... Of course, for the sake of effectiveness, safety, and tolerability, the current therapy is insufficient to confront the present hepatitis C epidemic. Therefore, from a therapy with poorly understood ...

7

Clinical and  aspects of Hepatitis B virus and Hepatitis C virus in FortalezaCeará

Clinical and aspects of Hepatitis B virus and Hepatitis C virus in FortalezaCeará

... Results: It was reported 779 cases of hepatitis B and 756 of hepatitis C. Regarding the HBV, 69.7% were male, 77.5% of brown color, and a median age of 36 years. Regarding risk factors, there was ...

8

Therapy of chronic hepatitis C: Virologic response monitoring

Therapy of chronic hepatitis C: Virologic response monitoring

... hepatitisa C, ali je mnogo značajnija u praćenju uspeha antivirusne ...hepatitisom C kod bolesnika koji su lečeni kombinovanom terapijom pegilo- vanim interferonom alfa i ...serumska hepatitis ...

5

A new evolutionary model for hepatitis C virus chronic infection.

A new evolutionary model for hepatitis C virus chronic infection.

... Hepatitis C virus (HCV) infects an estimated 3% of humanity [1] and is a leading global cause of liver disease and liver cancer [2]. Intervention is currently limited by the lack of a vaccine and of ...

4

Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients

Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients

... The mechanisms related to the spontaneous clearance of hepatitis C virus (HCV) have been primarily studied in regions where the infection is endemic. Results of prior studies have been extrapolated to ...

5

DIAGNOSIS OF HEPATITIS C VIRUS IN BRAZILIAN BLOOD DONORS USING A REVERSE TRANSCRIPTASE NESTED POLYMERASE CHAIN REACTION: COMPARISON WITH ENZYME IMMUNOASSAY AND RECOMBINANT PROTEIN IMMUNOBLOT ASSAY

DIAGNOSIS OF HEPATITIS C VIRUS IN BRAZILIAN BLOOD DONORS USING A REVERSE TRANSCRIPTASE NESTED POLYMERASE CHAIN REACTION: COMPARISON WITH ENZYME IMMUNOASSAY AND RECOMBINANT PROTEIN IMMUNOBLOT ASSAY

... Blood donors: Hepatitis C-infected blood donors in this study were identified during routine screening for HCV antibodies after blood donation. In our blood bank, annually around 30,000 units of blood are ...

5

PATIENTS WITH CHRONIC HEPATITIS C AND NORMAL TRANSAMINASES

PATIENTS WITH CHRONIC HEPATITIS C AND NORMAL TRANSAMINASES

... TRUGENE HCV 5’NC genotyping kit: a 244-bp fragment from the 5’NC of the HCV genome was amplified by RT-PCR using the COBAS AMPLICOR Hepatitis C test (Roche Molecular Systems, Inc., Branchburg, N.J.). The ...

5

Pathogenesis of Hepatitis C – HCV Consensus 2007

Pathogenesis of Hepatitis C – HCV Consensus 2007

... Some MHC class II alleles, such as DR5, have been associated with a lower incidence of cirrhosis in individuals chronically infected with HCV [94]. Rehermann et al. [95] identified CTLs restricted by histocompatibility ...

6

Hepatitis C: A Critical Analysis of Therapeutic Response Predictors

Hepatitis C: A Critical Analysis of Therapeutic Response Predictors

... Hepatitis C Virus is an RNA virus which may have certain degrees of transcription modifications in its genome, generating variants, defined as quasi-species. These are frequently developed under immune ...

8

Therapeutic Approach to Acute Hepatitis C

Therapeutic Approach to Acute Hepatitis C

... acute hepatitis C is generally asymptomatic, serologic triage and often HCV RNA testing are universally recommended strategies for correct diagnostic approach of intravenous drug users, patients infected ...

5

Molecular biology and clinical implication of hepatitis C virus

Molecular biology and clinical implication of hepatitis C virus

... Hepatitis C virus (HCV) was first described in 1989 as the putative viral agent of non-A non-B ...active hepatitis, cirrhosis and hepato- cellular ...

5

Treatment for Chronic Hepatitis C: Drugs and Treatment Response Patterns

Treatment for Chronic Hepatitis C: Drugs and Treatment Response Patterns

... The use of IFN-α was approved for hepatitis C treatment in 1991. At that time, the response to this immunotherapy was very low (< 20%). However, when the combination of ribavirin and IFN-α began to be ...

5

Hepatitis C Treatment Before and After Liver Transplant

Hepatitis C Treatment Before and After Liver Transplant

... The use of older liver donors is a factor that negatively affects the fibrosis progression rate. Recent studies show a tendency toward a ten-year increase in the age of donors in the last decade. This measure, although ...

5

Therapie der chronischen Hepatitis C Genotyp 1 – Update 2015

Therapie der chronischen Hepatitis C Genotyp 1 – Update 2015

... chronischen Hepatitis C stellen: Die Heilungsraten betragen fast 100 %, die Therapie hat keine relevanten Nebenwirkungen, ist für alle Pa- tienten – auch jene mit dekompensierter Leberzirrhose oder Status ...

11

Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study.

Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study.

... The hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and Treponema pallidum (TP) are blood-borne pathogens that are responsible for important infectious ...World ...

11

Hepatitis C and associated risks in prisons: an integrative review Hepatite C e riscos associados em presídios: uma revisão integrativa

Hepatitis C and associated risks in prisons: an integrative review Hepatite C e riscos associados em presídios: uma revisão integrativa

... The prison population is at high risk of contracting infections that are related to conditions of confinement, including viral hepatitis. The impact of HCV infection is not limited only to prison populations, ...

7

Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome

Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome

... for hepatitis C virus antibody detection (anti-HCV), using just one ...non-C hepatitis (10 acute hepatitis A, 10 acute hepatitis B, 9 chronic hepatitis B, and 10 ...

4

Chronic Hepatitis C: Pathological Anatomy

Chronic Hepatitis C: Pathological Anatomy

... the hepatitis C virus (HCV), there is a wide spectrum of histological alterations that can affect the liver, from acute hepatitis to mild reactive phenomena to more severe forms, including chronic ...

5

Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil

Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil

... The Monte Carlo simulation shows that the treatment with PegIFN alpha 2b, along an entire life time window, is cost- effective in 90.27% and 95.54% of the times, for patients with HCV genotypes 1 and non-1, respectively. ...

9

SEXUAL TRANSMISSION OF HEPATITIS C VIRUS

SEXUAL TRANSMISSION OF HEPATITIS C VIRUS

... not detect it in vaginal secretion, semen or saliva. Under these circumstances of low “infectivity”, an intact epithelium or local immunological factors probably play a role in the lack of HCV acquisition; with the ...

5

Show all 10000 documents...

temas relacionados